Title: Randomized Control Study To Analyse The Efficacy Budesonide Nasal Douching On Allergic Fungal Rhinosinusitis
Verma, H.; TR, S.; Murugesan, R.; Bhalla, A. S.; Madan, K.; Gupta, Y.; Srivastava, R. k.; Viswanathan, G. K.; Singh, G.; Thakar, A.; Kumar, R.; Sikka, K.; Pachaury, S. S.
Show abstract
INTRODUCTIONAllergic Fungal Rhinosinusitis is a hypersensitivity against fungal antigens. Primary surgical management is complimented with medical management in preoperative and postoperative phases for better intraoperative field & to limit the recurrence. The effect of systemic steroids & itraconazole showed promising outcomes as a solo agent or in combination under preoperative status. Recent studies showed auspicious conclusions with steroid-based nasal douches. The current study aims to assess the effectiveness of medical management in combination with steroid-based nasal douches. METHODOLOGYThis prospective study will recruit 40 clinico-radiological proven cases of AFRS after ethical approval. The study population will be randomized into two groups based on a computer program. Group A will receive systemic itraconazole and steroids & Group B will receive additional budesonide nasal douching. The outcomes will be studied clinically by SNOT-22 scoring system & Meltzer nasal polyp scoring system, biochemically with absolute eosinophil counts, aspergillus specific IgE and total IgE, radiologically with Lund-Mackay system and 20-point CT scoring system after 6 weeks of initiation of the treatment. ETHICS AND DISSEMINATIONWe received an AIIMS ethical board. Ref no-AIIMSA00641 dated 21.03.24 & CTRI (Clinical Trial Registry India) acknowledgement number - REF/2024/03/081566 dated 29. 03.24. We will follow the ethical committee protocol and instructions received from reviewers. STRENGTHSO_LIAFRS is a bothersome illness both for treating doctors and patients. This study is a pilot study on a combination of past and recently proven medical therapies for AFRS. C_LIO_LIThe study will generate data on new or complete medical management for AFRS. C_LIO_LIThe duration of planned treatment is 6 weeks. The study will generate data for future studies where prolonged medical treatment can be planned. C_LI LIMITATIONSO_LIThis will be a single-centred study. The validation for the expected outcome will require a multicentric study. C_LIO_LIThe study topic is planned for an MS student thesis so the follow-up period will be 3-6 months. C_LI
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Characteristics and outcome profile of Hospitalized African COVID-19 patients: The Ethiopian Context 94%
- COVID-19 Disease Severity and Determinants among Ethiopian Patients: A study of the Millennium COVID-19 Care Center 94%
- Prevalence, characteristics, and predictors of Long COVID among diagnosed cases of COVID-19 93%
Similar papers in this journal
Similar papers in this journal
- A Novel Maxillofacial Technology for Drug Administration-A Randomized Controlled Trial Using Metronidazole. 96%
- Comparison of Efficacy of Dexamethasone and Methylprednisolone in Improving the Partial Pressure of Arterial Oxygen and Fraction of Inspired Oxygen Ratio among COVID-19 Patients 95%
- Clearing the fog: Is Hydroxychloroquine effective in reducing Corona virus disease-2019 progression: A randomized controlled trial 94%
Similar papers in this journal
- Seroprevalence of SARS-CoV-2 in Niger State: A Pilot Cross Sectional Study 92%
- Covid-19 Associated Hepatitis in Children (CAHC) during the second wave of SARS-CoV-2 infections in Central India: Is it a complication or transient phenomenon 91%
- The Impact of SARS-CoV-2 Lineages (Variants) on the COVID-19 Epidemic in South Africa 91%
Similar papers in this journal
- Absence of Glutathione S-Transferase Theta 1 Gene is Significantly Associated with Breast Cancer Susceptibility in Pakistani Population and Poor Overall Survival in Breast Cancer Patients: A Case-Control and Case Series Analysis 90%
- Osthole Suppresses Prostate Cancer Progression by Modulating PRLR and the JAK2/STAT3 Signaling Axis 89%
- Alternative MyD88 -Cyclin D1 signaling in breast cancer cells regulates TLR3 mediated cell proliferation 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.